Top Markets
Coin of the day
Neurizon Therapeutics Limited Neurizon Therapeutics Limited

Neurizon Therapeutics Limited

NUZ
Clasificación en acciones #27538
Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops... Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases. The company develops drug discovery intellectual property for the treatment of neurological diseases. Its lead candidate is NUZ-001, a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as to treat other neurodegenerative diseases. The company was formerly known as PharmAust Limited and changed its name to Neurizon Therapeutics Limited in October 2024. Neurizon Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.
Precio por acción
$0.0416118
Capitalización bursátil
$32.25M
Cambio (1 día)
-1.67%
Cambio (1 año)
-59.58%
País
AU
Comercio Neurizon Therapeutics Limited (NUZ)

Categoría

Ratio P/B de Neurizon Therapeutics Limited (NUZ)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Neurizon Therapeutics Limited, el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Neurizon Therapeutics Limited desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
6.3419 -
US
3.7087 -
US
6.2413 -
NL
2.5054 -
AU
- -
CH